drugset

drugset / Trial / NCT00817505

To Evaluate the Bioavailability of a Tablet of AZD1656

NCT00817505 ↗

Phase 1 Completed 11 enrolled AstraZeneca

RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate the bioavailability of a tablet of AZD1656.

Timeline

Start: 2008-12
Primary completion: 2009-03
Completion: 2009-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	AZD1656	Small molecule	—	Oral

Indications